Solid Biosciences (SLDB) Return on Sales (2023 - 2024)
Historic Return on Sales for Solid Biosciences (SLDB) over the last 3 years, with Q4 2024 value amounting to 507.28%.
- Solid Biosciences' Return on Sales fell 2952800.0% to 507.28% in Q4 2024 from the same period last year, while for Dec 2024 it was 354.7%, marking a year-over-year decrease of 4478600.0%. This contributed to the annual value of 354.7% for FY2024, which is N/A changed from last year.
- Latest data reveals that Solid Biosciences reported Return on Sales of 507.28% as of Q4 2024, which was down 2952800.0% from 401.66% recorded in Q3 2024.
- Solid Biosciences' 5-year Return on Sales high stood at 905.26% for Q3 2023, and its period low was 12.73% during Q4 2022.
- In the last 3 years, Solid Biosciences' Return on Sales had a median value of 287.62% in 2024 and averaged 389.55%.
- In the last 5 years, Solid Biosciences' Return on Sales soared by 9126300bps in 2023 and then crashed by -6105200bps in 2024.
- Quarter analysis of 3 years shows Solid Biosciences' Return on Sales stood at 12.73% in 2022, then surged by 6406bps to 802.56% in 2023, then tumbled by -37bps to 507.28% in 2024.
- Its Return on Sales stands at 507.28% for Q4 2024, versus 401.66% for Q3 2024 and 287.62% for Q2 2024.